| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $749K | +4.2% | +1772.5% |
| R&D Expense | $14.7M | +32.3% | +18.6% |
| SG&A Expense | $14.5M | -2.7% | +41.3% |
| Operating Income | -$28.4M | -12.5% | -25.8% |
| Pre-tax Income | -$61.0M | -120.5% | -130.4% |
| Income Tax | $131K | +40.9% | +173.6% |
| Net Income | -$61.1M | -120.3% | -132.3% |
| EPS (Basic) | -$0.28 | -100.0% | -75.0% |
| EPS (Diluted) | -$0.28 | -100.0% | -75.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.4M | -50.9% | +1.5% |
| Current Assets | $130.7M | +27.3% | +14.5% |
| Total Assets | $239.8M | +26.8% | +21.4% |
| Current Liabilities | $16.5M | -35.2% | -15.8% |
| Long-term Debt | $0 | — | -100.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$55.2M | — | — |
| Capital Expenditures | $791K | — | — |
| Investing Cash Flow | -$68.8M | — | — |
| Financing Cash Flow | $127.1M | — | — |
| Free Cash Flow | -$56.0M | — | — |
| $79.9M |
| +76.5% |
| +56.1% |
| Stockholders' Equity | $159.8M | +11.1% | +9.6% |